Microport Cardioflow Medtech Corp
HKEX:2160

Watchlist Manager
Microport Cardioflow Medtech Corp Logo
Microport Cardioflow Medtech Corp
HKEX:2160
Watchlist
Price: 1.15 HKD 1.77% Market Closed
Market Cap: 2.8B HKD

Net Margin
Microport Cardioflow Medtech Corp

1.3%
Current
-99%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.3%
=
Net Income
4.9m
/
Revenue
367.5m

Net Margin Across Competitors

No Stocks Found

Microport Cardioflow Medtech Corp
Glance View

Market Cap
2.8B HKD
Industry
Health Care

MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The firm is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The firm's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The firm mainly conducts business within the domestic market.

Intrinsic Value
1.37 HKD
Undervaluation 16%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.3%
=
Net Income
4.9m
/
Revenue
367.5m
What is the Net Margin of Microport Cardioflow Medtech Corp?

Based on Microport Cardioflow Medtech Corp's most recent financial statements, the company has Net Margin of 1.3%.

Back to Top